Eupatilin
From Wikipedia, the free encyclopedia
 |
|
|
Eupatilin
|
|
| Systematic (IUPAC) name | |
| 2-(3,4-Dimethoxyphenyl)-5,7-dihydroxy-6-methoxychromen-4-one | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C18H16O7 |
| Mol. mass | 344.315 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Rx-only. Not available in the US, Canada or UK |
| Dependence Liability | None |
| Routes | Oral |
Eupatilin is a drug used in the treatment of acid-related disorders.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
